EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

75 hedge funds and large institutions have $55.5M invested in Eagle Pharmaceuticals, Inc. in 2024 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 41 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.66M
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$11M
2
$6.78M
3
$5.61M
4
$3.9M
5
$3.16M
6
$1.98M
7
$1.82M
8
$1.68M
9
$1.65M
10
$1.37M
11
$1.26M
12
$1.09M
13
$1.07M
14
$1.04M
15
$971K
16
$958K
17
$940K
18
$750K
19
$743K
20
$717K
21
$666K
22
$605K
23
$527K
24
$462K
25
$443K